BOLT — Bolt Biotherapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $8.42m
- -$19.09m
- $7.70m
Annual cashflow statement for Bolt Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -98.6 | -88.1 | -69.2 | -63.1 | -33.4 |
| Depreciation | |||||
| Non-Cash Items | 19.8 | 13 | 7.68 | 8.49 | 4.35 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 20.5 | -3.06 | -9.86 | -8.44 | -12.1 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -57.1 | -76.5 | -69.5 | -61.3 | -39.9 |
| Capital Expenditures | -2.34 | -1.95 | -0.206 | -0.041 | -0.072 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -230 | 59.8 | 71.2 | 57.6 | 44.4 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -232 | 57.9 | 71 | 57.6 | 44.3 |
| Financing Cash Flow Items | 0 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 311 | 0.503 | 0.253 | 0.108 | 0.019 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.8 | -18.1 | 1.77 | -3.6 | 4.47 |